Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 86, pseudogene (RNU6-86P)
- Target
- RNU6-86P
- Molecular classification
- Other (Pseudogene), Non-coding RNA-derived pseudogene, Not a receptor, enzyme, ion channel, transporter, or transcription factor
01
Overview
"RNA, U6 small nuclear 86, pseudogene" (RNU6-86P) refers to a non-coding pseudogene related to the highly conserved U6 small nuclear RNA (snRNA), which has an essential role in pre-mRNA splicing within the spliceosome[5]. Pseudogenes such as RNU6-86P arise through molecular mechanisms like retrotransposition or gene duplication but lack protein-coding capacity and generally do not participate actively in cellular processes[1]. RNU6-86P has no established biological activity, disease relevance, or therapeutic utility. The functional U6 snRNA, from which such pseudogenes are derived, is integral to the spliceosome for removing introns from nuclear pre-mRNAs[5][3]. Multiple copies and pseudogenes of U6 snRNA exist in the human genome as evolutionary remnants, highlighting the importance of its parental gene but not the pseudogenes themselves.
- Other names
- RNU6-86PU6 small nuclear RNA 86 pseudogeneRNA, U6 snRNA pseudogene 86
02
Mechanism of action
None for RNU6-86P; not a drug target For active U6 snRNA, no drugs directly target its splicing function in clinical settings[1][5].
03
Biological functions
None (pseudogenes are generally considered non-functional[1][5])May serve as transcriptomic relics, but RNU6-86P itself does not have an active biological functionU6 snRNA, the parental gene of such pseudogenes, is involved in pre-mRNA splicing as part of the spliceosome[5][3]
04
Disease associations
None established for RNU6-86PPseudogenes are sometimes implicated in gene regulation by acting as decoys or through transcriptional interference, but no direct evidence exists for RNU6-86PU6 snRNA (not the pseudogene) has broad relevance for splicing defects but not specifically for the pseudogene[3][1][5]
05
Safety considerations
None, since this is a pseudogene and not used as a therapeutic target
06
Interacting drugs
None. No drugs are known to interact with RNU6-86P or any U6 snRNA pseudogenes.
07
Biomarkers
None for RNU6-86PU6 snRNA (parental molecule) is sometimes used as a reference gene in qRT-PCR experiments as a normalization control for miRNA quantification[2].
Beyond the preview
Go deeper on RNA, U6 small nuclear 86, pseudogene (RNU6-86P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 86, pseudogene (RNU6-86P).